BACKGROUND: Depressive syndromes, including recurrent brief depression (RBD), have
frequently been observed in association with chronic diseases characterized by immune …

BACKGROUND: Interferon-α-(IFN-α) induced depression presents a challenge when
treating patients with the hepatitis C virus (HCV). Depression occurs in approximately one …

Immunotherapy with interferon-alpha (IFNα) may induce depressive symptoms, anxiety and
major depression when administered for at least 1–3 months at a dose of 3–10 MUI daily …

This study examined the incidence, clinical course and its risk factors for major depression in
patients with chronic hepatitis type C undergoing interferon-alpha therapy. Ninety-nine …

Thirty case reports published in Japan that refer to psychiatric symptoms accompanying
interferon (IFN) therapy were examined. These papers covered a total of 49 cases. We …

Aim. The purpose of the study was an assessment of the prevalence of depressive
symptoms and characteristic of cognitive functions in patients with hepatitis C before and …

Imputability of thymic disorders caused by IFNα during the chronic Hepatitis C treatment–
hepatitis C and depression–The infection by the hepatitis C virus (HCV) is a major public …

There is increasing evidence of psychiatric side-effects following long-term alpha-interferon
treatment, but no previous reports of psychosis as a side-effect. There is little evidence to …

OBJECTIVE: Neuropsychiatric symptoms are commonly associated with chronic hepatitis C
virus infection, its sequelae, and its treatment. In particular, interferon, a primary component …

Objective To evaluate the efficacy of a herbal medicine (Mao‐to) on psychiatric
complications caused by IFN, and to examine the relationship between depression and …